Terms: = Endocrine gland cancer AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL AND Prognosis
45 results:
1. Identifying and analyzing the key genes shared by papillary thyroid carcinoma and Hashimoto's thyroiditis using bioinformatics methods.
Liu TT; Yin DT; Wang N; Li N; Dong G; Peng MF
Front Endocrinol (Lausanne); 2023; 14():1140094. PubMed ID: 37324256
[TBL] [Abstract] [Full Text] [Related]
2. Lymphocyte-activation gene 3 protein expression in tumor-infiltrating lymphocytes is associated with a poor prognosis of ovarian clear cell carcinoma.
Zaitsu S; Yano M; Adachi S; Miwa M; Katoh T; Kawano Y; Yasuda M
J Ovarian Res; 2023 May; 16(1):93. PubMed ID: 37179337
[TBL] [Abstract] [Full Text] [Related]
3. Incidence and appropriate management of drug-induced interstitial lung disease in Japanese patients with unresectable pancreatic cancer: A multicenter retrospective study.
Miyagahara T; Fujimori N; Ueda K; Takamatsu Y; Matsumoto K; Teramatsu K; Takaoka T; Suehiro Y; Shimokawa Y; Omori K; Niina Y; Tachibana Y; Akashi T; Oono T; Ogawa Y
Asia Pac J Clin Oncol; 2023 Aug; 19(4):533-541. PubMed ID: 36478079
[TBL] [Abstract] [Full Text] [Related]
4. Comparison of MRI and CT-based radiomics for preoperative prediction of lymph node metastasis in pancreatic ductal adenocarcinoma.
Zeng P; Qu C; Liu J; Cui J; Liu X; Xiu D; Yuan H
Acta Radiol; 2023 Jul; 64(7):2221-2228. PubMed ID: 36474439
[TBL] [Abstract] [Full Text] [Related]
5. Therapeutic potential of an anti-CCR9 mAb evidenced in xenografts of human CCR9
Santamaria S; Delgado M; Botas M; Castellano E; Corraliza-Gorjon I; Lafuente P; Muñoz-Calleja C; Toribio ML; Kremer L; Garcia-Sanz JA
Front Immunol; 2022; 13():825635. PubMed ID: 35967322
[TBL] [Abstract] [Full Text] [Related]
6. Prokineticins as a Prognostic Biomarker for Low-Grade Gliomas: A Study Based on The cancer Genome Atlas Data.
Zhong J; Xiang D; Ma X
Biomed Res Int; 2022; 2022():2309339. PubMed ID: 35845958
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic value of complete metabolic response on ¹⁸F-FDG-PET/CT after three cycles of neoadjuvant chemotherapy in advanced high-grade serous ovarian cancer.
Chung YS; Kim Y; Kim HS; Lee JY; Kang WJ; Kim S; Kim SW
J Gynecol Oncol; 2022 May; 33(3):e28. PubMed ID: 35128858
[TBL] [Abstract] [Full Text] [Related]
8. Retrospective review of cutaneous metastasis among 11,418 patients with solid malignancy: A tertiary cancer center experience.
Teyateeti P; Ungtrakul T
Medicine (Baltimore); 2021 Jul; 100(29):e26737. PubMed ID: 34398051
[TBL] [Abstract] [Full Text] [Related]
9. CircCCT3 Acts as a Sponge of miR-613 to Promote Tumor Growth of Pancreatic cancer Through Regulating VEGFA/VEGFR2 Signaling.
Hou JP; Men XB; Yang LY; Han EK; Han CQ; Liu LB
Balkan Med J; 2021 Jul; 38(4):229-238. PubMed ID: 34274912
[TBL] [Abstract] [Full Text] [Related]
10. Ovarian Sparing Surgery in Mature Ovarian Teratomas in Children: A 20-Year Single-Center Experience.
Szymon O; Bogusz B; Taczanowska-Niemczuk A; Maślanka M; Górecki W
Eur J Pediatr Surg; 2021 Feb; 31(1):2-7. PubMed ID: 32950035
[TBL] [Abstract] [Full Text] [Related]
11. Quality of Life in Papillary Thyroid Microcarcinoma Patients Undergoing Radiofrequency Ablation or Surgery: A Comparative Study.
Lan Y; Luo Y; Zhang M; Jin Z; Xiao J; Yan L; Zhu Y
Front Endocrinol (Lausanne); 2020; 11():249. PubMed ID: 32499754
[No Abstract] [Full Text] [Related]
12. Prognostic value of LAT-1 status in solid cancer: A systematic review and meta-analysis.
Lu JJ; Li P; Yang Y; Wang L; Zhang Y; Zhu JY; Zhu XR; Chen MB
PLoS One; 2020; 15(5):e0233629. PubMed ID: 32469987
[TBL] [Abstract] [Full Text] [Related]
13. Effect of neoadjuvant radiotherapy on survival of non-metastatic pancreatic ductal adenocarcinoma: a SEER database analysis.
Wang D; Liu C; Zhou Y; Yan T; Li C; Yang Q; Xu Y; Zhao L; Pei Q; Tan F; Güngör C; Li Y
Radiat Oncol; 2020 May; 15(1):107. PubMed ID: 32404114
[TBL] [Abstract] [Full Text] [Related]
14. Identification of germline and somatic mutations in pancreatic adenosquamous carcinoma using whole exome sequencing.
Ma H; Song B; Guo S; Li G; Jin G
Cancer Biomark; 2020; 27(3):389-397. PubMed ID: 31958074
[TBL] [Abstract] [Full Text] [Related]
15. Outcomes of Patients with Nelson's Syndrome after Primary Treatment: A Multicenter Study from 13 UK Pituitary Centers.
Fountas A; Lim ES; Drake WM; Powlson AS; Gurnell M; Martin NM; Seejore K; Murray RD; MacFarlane J; Ahluwalia R; Swords F; Ashraf M; Pal A; Chong Z; Freel M; Balafshan T; Purewal TS; Speak RG; Newell-Price J; Higham CE; Hussein Z; Baldeweg SE; Dales J; Reddy N; Levy MJ; Karavitaki N
J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 31735971
[TBL] [Abstract] [Full Text] [Related]
16. High Co-expression of Large Tenascin C Splice Variants in Stromal Tissue and Annexin A2 in cancer Cell Membranes is Associated with Poor prognosis in Pancreatic cancer.
Hagiwara K; Harimoto N; Yokobori T; Muranushi R; Hoshino K; Gantumur D; Yamanaka T; Ishii N; Tsukagoshi M; Igarashi T; Tanaka H; Watanabe A; Kubo N; Araki K; Hosouchi Y; Shirabe K
Ann Surg Oncol; 2020 Mar; 27(3):924-930. PubMed ID: 31463696
[TBL] [Abstract] [Full Text] [Related]
17. [Analysis of risk factors for central lymph node metastasis in papillary thyroid microcarcinoma].
Wang ZH; Zhang YJ; Fu GM; Chen YB
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jan; 54(1):12-17. PubMed ID: 30704163
[No Abstract] [Full Text] [Related]
18. Prognostic value of volume-based metabolic parameters of
Han S; Kim H; Kim YJ; Suh CH; Woo S
Ann Nucl Med; 2018 Dec; 32(10):669-677. PubMed ID: 30101392
[TBL] [Abstract] [Full Text] [Related]
19. Risk of Hematologic Malignancies After Radioiodine Treatment of Well-Differentiated Thyroid cancer.
Molenaar RJ; Sidana S; Radivoyevitch T; Advani AS; Gerds AT; Carraway HE; Angelini D; Kalaycio M; Nazha A; Adelstein DJ; Nasr C; Maciejewski JP; Majhail NS; Sekeres MA; Mukherjee S
J Clin Oncol; 2018 Jun; 36(18):1831-1839. PubMed ID: 29252123
[TBL] [Abstract] [Full Text] [Related]
20. LncRNA HOTAIR acts a competing endogenous RNA to control the expression of notch3 via sponging miR-613 in pancreatic cancer.
Cai H; Yao J; An Y; Chen X; Chen W; Wu D; Luo B; Yang Y; Jiang Y; Sun D; He X
Oncotarget; 2017 May; 8(20):32905-32917. PubMed ID: 28415631
[TBL] [Abstract] [Full Text] [Related]
[Next]
